• Agora
  • Eioc Mededge
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: Bayer: 10 Blockbusters in 10 Years?
Share
Notification
  • Agora
  • Eioc Mededge
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > News > Bayer: 10 Blockbusters in 10 Years?
NewsLead

Bayer: 10 Blockbusters in 10 Years?

ME Desk
ME Desk
Published: June 20, 2024
Share
3 Min Read
Bayer: 10 Blockbusters in 10 Years?
SHARE

Chicago, USA- June 17, 2024- Bayer aims to launch ten blockbuster products in the next ten years to support farmers worldwide, the company announced at its 2024 Crop Science innovation update in Chicago. Each blockbuster is expected to contribute more than 500 million euros of the over 32-billion-euros peak sales potential in the R&D pipeline – unparalleled across the global agricultural industry. Farmers will benefit from new technologies that will help them produce more while restoring nature through innovations that power regenerative agriculture.

Bayer is on its way to scale regenerative agriculture on more than 400 million acres globally by the middle of the next decade. The company considers regenerative agriculture as an outcome-based production model, with improving soil health as a key component, leading to increased resilience. Other key aspects include increased productivity; adaption and mitigation of climate change through reductions in greenhouse gas emissions; increased carbon sequestration in the soil; maintaining, preserving or restoring on-farm biodiversity; conserving water resources through improved water retention, reduction in water run-off, as well as improved social and economic well-being of farmers and their communities.

Also Read: Bayer and Aignostics to collaborate on next-generation precision oncology

“Agriculture needs to change for the better, there’s no relying on what has been working in the past. We deliver a combination of unmatched innovation that goes hand in hand with key regenerative practices to help address two of the biggest challenges of our time: ensuring food security for a growing population and fighting climate change,” said Frank Terhorst, Head of Strategy and Sustainability at Bayer’s Crop Science Division.

Bob Reiter, Head of R&D, added: “The age of single and isolated technologies is over. We are focusing on closely connected agricultural systems that combine seeds, traits, crop protection and digital solutions in a smart way to benefit the farmers and the environment. To this end, we are leveraging key technology platforms like gene editing, precision breeding, small molecules and biologicals to deliver products that farmers need to make agriculture more productive while reducing the carbon footprint and fostering biodiversity at a global scale.”

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article New Labcorp initiative aims to bring new therapies to market faster New Labcorp initiative aims to bring new therapies to market faster
Next Article Swissport Retains IATA's Pharma Logistics Approval in Frankfurt Swissport Retains IATA’s Pharma Logistics Approval in Frankfurt

Recent Posts

  • Suriname Certified Malaria-free by WHO
  • Danaher Appoints Martin Stumpe as Chief Technology and AI Officer
  • IFRC Calls for Increased International Support as Afghan Population Movement from Iran Intensifies
  • Kyverna Therapeutics Announces Appointment of New Chief Financial Officer
  • From Skin Types to Chronic Conditions: Dr. Jawaher Al Naqbi | AIDA 2025
  • LifeSpin
  • Health ExpoIraq
  • Agora
  • Holistic Health Middle East
  • Holistic Health Middle East MedEdge
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Bayer: 10 Blockbusters in 10 Years?
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Bayer: 10 Blockbusters in 10 Years?
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?